Skip to Content

Hisamitsu Pharmaceutical Co Inc HTSUF Stock Quote

| Rating as of

PINX: HTSUF

Market Closed

| Currency in USD

  • Last Close 36.00
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Mid Blend
  • Day Range 36.00  –  36.00
  • Year Range 23.36  –  36.00
  • Market Cap 2.7898 Bil
  • Volume / Avg 229.0 /  356.6
  • Price / Sales 2.90
  • Price / Book 1.51
  • Forward Div Yield 2.21%
  • Trailing Div Yield 235.42%

Morningstar‘s Stock Analysis HTSUF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics HTSUF

Company Profile HTSUF

Business Description

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Contact
408 Tashiro Daikan-machi, Tosu
Saga, 841-0017, JPN
Industry Drug Manufacturers - Specialty & Generic
Employees 3,643

Competitors & Peers HTSUF

Morningstar does not cover competitors or peers for this firm.

FAQs for Hisamitsu Pharmaceutical Co Inc Stock

Yes. HTSUF has a forward dividend yield of 1.77%. See HTSUF’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

HTSUF’s market cap is 2.79 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

HTSUF’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

HTSUF’s price/sales is 2.90.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

HTSUF’s price/forward earnings is 27.42.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

HTSUF’s price/book is 1.51.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See HTSUF’s valuation ratios compared to the Market Index.

HTSUF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare HTSUF’s historical performance against its industry peers and the overall market.